KG
CLB icon

Kilter Group’s Core Laboratories CLB Stock Holding History

Kilter Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31K Buy
198
+138
+230% +$1.97K ﹤0.01% 969
2026
Q1 		$1.01K Buy
+60
New +$1.07K ﹤0.01% 1230
2025
Q3 		– Sell
-21
Closed -$242 – 1234
2025
Q2 		$242 Buy
+21
New +$249 ﹤0.01% 1087

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Kilter Group's CLB Position: Q2 2026 in Review

Kilter Group increased its Core Laboratories (CLB) stake by 230% in Q2 2026, buying an estimated $1.97K and bringing the position to 198 shares worth $2.31K. The position accounts for ﹤0.01% of the portfolio, ranked #969.

Kilter Group first reported a position in CLB in Q2 2025 and has held it in 3 quarters since. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Kilter Group held 198 shares of Core Laboratories worth $2.31K as of Q2 2026.
  • Kilter Group bought 138 Core Laboratories shares in Q2 2026, an estimated $1.97K.
  • Core Laboratories made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #969 holding.
  • Kilter Group first reported a position in Core Laboratories in Q2 2025 and has held it in 3 quarters since.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.